Hydergine LC en es it fr

Hydergine LC Brand names, Hydergine LC Analogs

Hydergine LC Brand Names Mixture

  • No information avaliable

Hydergine LC Chemical_Formula


Hydergine LC RX_link

No information avaliable

Hydergine LC fda sheet

Hydergine LC msds (material safety sheet)

Hydergine LC Synthesis Reference

No information avaliable

Hydergine LC Molecular Weight

591.741 g/mol

Hydergine LC Melting Point

No information avaliable

Hydergine LC H2O Solubility

No information avaliable

Hydergine LC State


Hydergine LC LogP


Hydergine LC Dosage Forms

Capsule; Liquid; Powder; Powder for solution; Solution; Syrup; Tablet

Hydergine LC Indication

For use as an adjunct therapy for patients with dementia

Hydergine LC Pharmacology

Ergoloid Mesylate may increase cerebral metabolism and blood flow. The role of this medication in the therapy of dementia is controversial. A recent controlled study in patients with Alzheimer's disease found that there was no advantage to the use of ergoloid mesylates compared to placebo, suggesting that ergoloid mesylates may lower scores on some cognitive and behavioral rating scales. Further study is needed to determine the risk-benefit profile of ergoloid mesylates in the treatment of dementia.

Hydergine LC Absorption

Rapidly but incompletely (approximately 25%) absorbed from the gastrointestinal tract. Approximately 50% of the absorbed dose is eliminated by first-pass metabolism.

Hydergine LC side effects and Toxicity

Symptoms of overdose include dyspnea, hypotension or hypertension, rapid weak pulse, delirium, nausea, vomiting, and bradycardia.

Hydergine LC Patient Information

No information avaliable

Hydergine LC Organisms Affected

Humans and other mammals